Randomized Trial for High-risk Cutaneous Squamous Cell Carcinoma Patients Treated With Adjuvant Cemiplimab
High-risk patients with cutaneous squamous cell carcinoma (CSCC) have an unmet need with regard to...
Read More
Meeting Coverage
Most With MS Experience Early-Onset Fatigue
Most individuals with MS reported mild fatigue early in their disease course, at least one-half of...
Read More
Wellness Program Improves Disease Markers & Physical Activity in Patients With MS
Patients with MS who participated in a weekly, structured wellness program demonstrated ongoing,...
Read More
SKYSCRAPER-02: Additional Tiragolumab Does Not Help Patients With Untreated SCLC
Tiragolumab, added to atezolizumab, carboplatin, and etoposide, did not improve the...
Read MoreASCO Voices Event
This year ASCO Voices will be held on Saturday, June 4, from 12:00 PM – 1:00 PM CDT, at the Arie Crown Theater in McCormick Place Here are this year’s ASCO Voices: Cancer: Common Humanity, Different Worlds Kevin...
Read MoreASCO Voices Event
This year ASCO Voices will be held on Saturday, June 4, from 12:00 PM – 1:00 PM CDT, at the Arie Crown Theater in McCormick Place Here are this year’s ASCO Voices: Cancer: Common Humanity, Different Worlds Kevin...
Read MoreASCO Voices Event
This year ASCO Voices will be held on Saturday, June 4, from 12:00 PM – 1:00 PM CDT, at the Arie Crown Theater in McCormick Place Here are this year’s ASCO Voices: Cancer: Common Humanity, Different Worlds Kevin...
Read MoreContinuing Education At ASCO 2022
Sessions at the 2022 ASCO Annual Meeting offer Continuing Medical Education (CME) credits and ABIM and ABP Maintenance of Certification (MOC) points for physicians. Nursing and pharmacy CE credits will not be provided this year,...
Read MoreContinuing Education At ASCO 2022
Sessions at the 2022 ASCO Annual Meeting offer Continuing Medical Education (CME) credits and ABIM and ABP Maintenance of Certification (MOC) points for physicians. Nursing and pharmacy CE credits will not be provided this year,...
Read MoreContinuing Education At ASCO 2022
Sessions at the 2022 ASCO Annual Meeting offer Continuing Medical Education (CME) credits and ABIM and ABP Maintenance of Certification (MOC) points for physicians. Nursing and pharmacy CE credits will not be provided this year,...
Read MoreWhy To Attend ASCO 2022
Join more than 40,000 oncology professionals from around the world at the 2022 ASCO Annual Meeting. Stay up to date on new clinical cancer advances in every area of cancer research, gain real-time insights from world-renown...
Read MoreWhy To Attend ASCO 2022
Join more than 40,000 oncology professionals from around the world at the 2022 ASCO Annual Meeting. Stay up to date on new clinical cancer advances in every area of cancer research, gain real-time insights from world-renown...
Read MoreWhy To Attend ASCO 2022
Join more than 40,000 oncology professionals from around the world at the 2022 ASCO Annual Meeting. Stay up to date on new clinical cancer advances in every area of cancer research, gain real-time insights from world-renown...
Read More
YAP-1: Immunotherapy Efficacy in ES-SCLC Patients
In extensive-stage small-cell lung cancer (ES-SCLC), IMpower133 improved progression-free survival...
Read More
Low-Dose Radiotherapy Plus Atezolizumab & Chemotherapy Benefits ES-SCLC
Researchers conducted the MATCH study to assess the clinical benefits of adding low-dose...
Read More
ES-SCLC: Anti-PD-L1 Blockades With Etoposide & Platinum
According to IMpower133 and CASPIAN, anti-PD-L1 blockades combined with etoposide and platinum...
Read More
Neoadjuvant Immunotherapy for Advanced, Resectable CSCC-HN
Researchers studied neoadjuvant immunotherapy to produce a pathologic response in patients with...
Read More
Usage of Immunotherapy in Merkel Cell Carcinoma
Merkel Cell Carcinoma (MCC) was rare, and aggressive skin cancer became more common as the...
Read More
Treatment Resistant HPV+ Head & Neck Squamous Cell Carcinoma
Cancer’s biological behavior was exceedingly complex, driven by the nonlinear interplay of...
Read More
Age Associated Mutation in Cutaneous Squamous Cell Carcinoma
Cutaneous squamous cell carcinoma was the most frequent type of skin cancer globally. The presence...
Read More